Work

Targeting anti-cancer agents to bone using bisphosphonates

Year: 2020

Type: article

Source: Bone

DOI: 10.1016/j.bone.2020.115492

Authors: Lianping Xing, Frank H. Ebetino, Robert K. Boeckman, Venkat Srinivasan, Jianguo Tao, Tomi K. Sawyer, Jinbo Li, Zhenqiang Yao, Brendan F. Boyce

Institutions: University of Rochester Medicine, University of Rochester, BioVinc (United States)

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Dental and Craniofacial Research

Awards: Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment, G2557006295, G2610294599, G2728952689, G418884287, G4701143036, Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy, G5642499405, Bone targeted antimicrobials for the treatment of diabetic foot related infections and osteomyelitis, Studies of TRAF3 in age-related low-level chronic inflammation and osteoporosis, G9000103139, G9000173709, G9000264361, G9000274526

OpenAlex ID: W3036448610

FWCI: 2.246

Cites: 86

Cited by: 46

Related to: 10